ArticleBioengineered2022

Pirfenidone attenuates cardiac hypertrophy against isoproterenol by inhibiting activation of the janus tyrosine kinase-2/signal transducer and activator of transcription 3 (JAK-2/STAT3) signaling pathway.

Zhenhuan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.